Amedisys (NASDAQ:AMED) Posts Quarterly Earnings Results, Beats Expectations By $0.15 EPS

Key Points

• Amedisys (NASDAQ:AMED) reported a quarterly earnings per share (EPS) of $1.54, exceeding estimates by $0.15.
• Stock prices saw a 0.6% increase, reaching $97.52, with a market capitalization of $3.20 billion.
• Major institutional investors have significantly increased their holdings in Amedisys, with AQR Capital Management boosting its stake by 98.3%.

Amedisys (NASDAQ:AMED - Get Free Report) issued its quarterly earnings results on Tuesday. The health services provider reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.15, Zacks reports. Amedisys had a net margin of 3.79% and a return on equity of 12.52%.

Amedisys Stock Up 0.6%

Shares of NASDAQ AMED traded up $0.61 during trading hours on Tuesday, hitting $97.52. The company had a trading volume of 395,180 shares, compared to its average volume of 357,705. The stock has a market capitalization of $3.20 billion, a P/E ratio of 35.99, a price-to-earnings-growth ratio of 1.33 and a beta of 0.94. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.27. Amedisys has a 1-year low of $82.15 and a 1-year high of $98.62. The firm's 50 day moving average is $96.39 and its 200-day moving average is $94.02.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on AMED shares. Royal Bank Of Canada restated an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research report on Wednesday, April 16th. Wall Street Zen downgraded shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th.

Institutional Investors Weigh In On Amedisys

Several large investors have recently made changes to their positions in the stock. AQR Capital Management LLC lifted its holdings in Amedisys by 98.3% during the 1st quarter. AQR Capital Management LLC now owns 13,410 shares of the health services provider's stock valued at $1,242,000 after purchasing an additional 6,646 shares during the last quarter. Great Lakes Advisors LLC acquired a new stake in Amedisys during the 1st quarter valued at $214,000. Empowered Funds LLC lifted its holdings in Amedisys by 10.1% during the 1st quarter. Empowered Funds LLC now owns 3,854 shares of the health services provider's stock valued at $357,000 after purchasing an additional 354 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Amedisys by 9.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,990 shares of the health services provider's stock valued at $184,000 after purchasing an additional 176 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company's stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.